These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34283701)

  • 21. Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials.
    Murphy SM; Jeng PJ; Poole SA; Jalali A; Vocci FJ; Gordon MS; Woody GE; Polsky D
    Addict Sci Clin Pract; 2020 Apr; 15(1):15. PubMed ID: 32321570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated.
    Klemperer EM; Evans EA; Rawson R
    Prev Med; 2023 Nov; 176():107647. PubMed ID: 37499918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fostering MOUD use in justice populations: Assessing the comparative effectiveness of two favored implementation strategies to increase MOUD use.
    Molfenter T; Vechinski J; Taxman FS; Breno AJ; Shaw CC; Perez HA
    J Subst Abuse Treat; 2021 Sep; 128():108370. PubMed ID: 33762145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.
    Grella CE; Ostile E; Scott CK; Dennis M; Carnavale J
    Int J Drug Policy; 2020 Jul; 81():102768. PubMed ID: 32446130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration.
    Gryczynski J; Lee JD; Dusek K; McDonald R; Sharma A; Malone M; Monico LB; Cheng A; DeVeaugh-Geiss A; Chilcoat HD
    J Subst Abuse Treat; 2021 Aug; 127():108349. PubMed ID: 34134866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program.
    Tofighi B; Isaacs N; Byrnes-Enoch H; Lakew R; Lee JD; Berry C; Schatz D
    J Subst Abuse Treat; 2019 Nov; 106():1-3. PubMed ID: 31540604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biopsychosocial contexts of timely and adequate prenatal care utilization among women with criminal legal involvement and opioid use disorder.
    Satcher MF; Bruce ML; Goodman DJ; Lord SE
    BMC Public Health; 2023 Apr; 23(1):729. PubMed ID: 37085842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery support specialists inside the jail: a program description of treatment engagement for opioid use disorder.
    Martin M; Phillips MA; Saxon M; Love K; Cessna L; Woodard DL; Page M; Curry K; Paone A; Pennington-Stallcup B; Riley W
    Int J Prison Health; 2021 Nov; 17(4):497-508. PubMed ID: 38902903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Criminal justice continuum for opioid users at risk of overdose.
    Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
    Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum.
    Lien IC; Seaton R; Szpytman A; Chou J; Webber V; Waineo E; Levine D
    Med Educ Online; 2021 Dec; 26(1):1847755. PubMed ID: 33222656
    [No Abstract]   [Full Text] [Related]  

  • 31. Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis.
    Bahji A; Carlone D; Altomare J
    Addiction; 2020 Aug; 115(8):1413-1425. PubMed ID: 31863669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives.
    Yatsco AJ; Champagne-Langabeer T; Holder TF; Stotts AL; Langabeer JR
    Int J Drug Policy; 2020 Sep; 83():102849. PubMed ID: 32653668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perceptions of Community Corrections and Treatment Experience: A Qualitative Study Among People With Incarceration Histories Receiving Outpatient Methadone Treatment.
    Gaeta Gazzola M; Oberleitner LMS; Hoffman K; Eller A; Madden LM; Marcus R; Oberleitner D; Beitel M; Thompson E; Zheng X; Barry DT
    Subst Use Addctn J; 2024 Oct; 45(4):568-576. PubMed ID: 38551080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Online Medication Assisted Treatment Education for Court Professionals: Need, Opportunities and Challenges.
    Matusow H; Rosenblum A; Fong C
    Subst Use Misuse; 2021; 56(10):1439-1447. PubMed ID: 34154519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medications for Opioid Use Disorder During Incarceration.
    McDermott-Winger ER; Latham CL
    J Addict Nurs; 2022 Jul-Sep 01; 33(3):182-190. PubMed ID: 36041161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Just fighting for my life to stay alive": a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories.
    Hoffman KA; Thompson E; Gaeta Gazzola M; Oberleitner LMS; Eller A; Madden LM; Marcus R; Oberleitner DE; Beitel M; Barry DT
    Addict Sci Clin Pract; 2023 Mar; 18(1):16. PubMed ID: 36944998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults.
    Adams ZW; Taylor BG; Flanagan E; Kwon E; Johnson-Kwochka AV; Elkington KS; Becan JE; Aalsma MC
    J Adolesc Health; 2021 Aug; 69(2):321-328. PubMed ID: 33579622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder.
    Truong AY; Saway BF; Bouzaher MH; Rasheed MN; Monjazeb S; Everest SD; Giampalmo SL; Hartman D; Hartman C; Kablinger AS; Trestman RL
    BMC Psychiatry; 2021 Jan; 21(1):23. PubMed ID: 33423661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Criminal Justice Barriers to Treatment of Opioid Use Disorders in the United States: The Need for Public Health Advocacy.
    Csete J
    Am J Public Health; 2019 Mar; 109(3):419-422. PubMed ID: 30676805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.